REFERENCES
- Aoki H., Sun C., Fuji K., Miyajima K. Disposition kinetics of liposomes modified with synthetic aminoglycolipids in rats. Int. J. Pharm. 1995; 15: 183–191
- Baş A. L., Elmas M., Şimşek A., et al. Efficacies of free and liposome-encapsulated enrofloxacin (Baytril®) against Staphylococcus aureus infection in Turkish shepherd dog neutrophils in vitro. Rev. Med. Vet. 2000; 151: 415–420
- Baş A. L., Şimşek A., Çorlu M., et al. Determination of intracellular concentration of free and two types of liposomes-encapsulated enrofloxacin in anatolian shepherd dog monocytes. J. Vet. Med. B. 2002; 49: 1–5
- Bedrad J., Bryan L. E. Interaction of the fluroquinolone antimicrobial agents ciprofloxacin and enoxacin with liposomes. Antimicrob. Agents Ch. 1989; 33: 1379–1382
- Belsito S., Bartucci R., Sportelli L. Paclitaxel interaction with phospholipid bilayers: high-sensitivity differential scanning calorimetric study. Thermochim. Acta 2005; 427: 175–180
- Cabanes A., Reig F., Anton J. M. G., Arboix M. Sustained release of liposome-encapsulated enrofloxacin after intramuscular administration in rabbits. Am. J. Vet. Res. 1995; 56: 1498–1501
- Castelli F., Caruso S., Giuffrida N. Different effects of two structurally similar carotenoids, lutein and b-carotene, on the thermotropic behaviour of phosphatidylcholine liposomes. Calorimetric evidence of their hindered transport through biomembranes. Thermochim. Acta 1999; 327: 125–131
- Castelli F., Raudino A., Fresta M. A mechanistic study of the permeation kinetics through biomembrane models: Gemcitabine–phospholipid bilayer interaction. J. Colloid. Interf. Sci. 2005; 285: 110–117
- Grabielle-Madelmont C., Lesieur S., Ollivon M. Characterization of loaded liposomes by size exclusion chromatography. J. Biochem. Biophys. Meth. 2003; 56: 189–217
- Kulkarni S. B., Betageri G. V., Singh M. Factor affecting microencapsulation of drug in liposomes. J. Microencapsul. 1995; 12: 229–246
- Lang J. K., Vigo-Pelfrey C. Quality control of liposomal lipids with special emphasis on peroxidation of phospholipids and cholesterol. Chem. Phys. Lipids. 1993; 64: 19–29
- Lian T., Ho R. J. Y. Trends and developments in liposome drug delivery systems. J. Pharm. Sci. 2001; 90: 667–680
- Lizondo M., Pons M., Gallardo M., Estelrich J. Physicochemical properties of enrofloxacin. J. Pharm. Biomed. Anal. 1997; 15: 1845–1849
- Maurer N., Wong K. F., Hope M. J., Cullis P. R. Anomalous solubility behavior of the antibiotic ciprofloxacin encapsulated in liposomes: a 1H-NMR study. Biochim. Biophys. Acta 1998; 1374: 9–20
- Montero M. T., Carrera I., Hernandez-Borrell J. Encapsulation of a quinolone in liposomes. Location and effect on lipid bilayers. J. Microencapsul 1994; 11: 423–430
- Mohammeda A. R., Westonb N., Coombesa A. G. A., et al. Liposome formulation of poorly water soluble drugs: optimisation of drug loading and ESEM analysis of stability. Int. J. Pharm. 2004; 285: 23–34
- New R. R. C. Influence of liposome characteristics on their properties and fate. Liposome as Tools in Basic Research and Industry, J. R. Philippot, F. Schuber. CRC Press, Florida 1995; 4–20
- Plessis J., Ramachandran C., Weiner N., Müller D. G. The influence of lipid composition and lamellarity of liposomes on the physical stability of liposomes upon storage. Int. J. Pharm. 1996; 127: 273–278
- Pons M., Foradada M., Esteirich J. Liposomes obtained by the ethanol injection method. Int. J. Pharm. 1993; 95: 51–56
- Puglisi G., Fresta M., Mazzone G., et al. Formulation parameters of fluoroquinolone-loaded liposomes and in vitro antimicrobial activity. Int. J. Pharm. 1995; 118: 65–76
- Sezer A. D., Baş A. L., Akbuğa J. Effect of formulation variables on the characteristics of enrofloxacin liposomes. 62nd International World Congress of FIP, NiceFrance, August–5 September, 31, 2002; 28
- Sezer A. D., Baş A. L., Akbuğa J. Encapsulation of enrofloxacin in liposomes I: in vito characterization of LUV. J. Liposome Res. 2004; 14(1–2)77–86
- Vays S. P., Goswami S. K., Singh R. Liposomes based nasal delivery system of nifedipine: development and characterization. Int. J. Pharm. 1995; 118: 23–30